Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

ASTRO selects five more treatments to scrutinize as part of Choosing Wisely initiative

The American Society for Radiation Oncology (ASTRO) expanded on its recommendations for the national Choosing Wisely campaign, adding five targeted treatment options to the list of procedures that should be carefully scrutinized before being prescribed.

Agendia test for molecular subtyping of breast cancer is a better guide to pre-surgical treatment

In findings that could eventually change the way breast cancer is treated, a study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of breast cancer than does conventional IHC-FISH pathology testing.

Shortening androgen deprivation therapy can boost quality of life for prostate cancer patients

A shorter course of androgen deprivation therapy (ADT) can improve quality of life for high-risk prostate cancer patients by helping them recover a normal testosterone level in a shorter amount of time, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting in San Francisco.

Eli Lilly funds lawsuit against CMS for limiting amyloid imaging

Makers of F-18 florbetapir (Amyvid) are bankrolling a lawsuit against the Centers for Medicare & Medicaid Services (CMS), which hampered coverage of amyloid imaging earlier this year as a means for ruling out Alzheimer’s disease. The lawsuit was filed in federal court by Lilly and others Sept. 5, according to this Wall Street Journal report.

Thumbnail

Ga-68 DOTATATE PET/CT finds more NETs

A comparison study of three different methods of neuroendocrine tumor (NET) detection that includes PET/CT, SPECT/CT and whole body MR imaging places PET/CT with gallium-68 (Ga-68) DOTATATE on a pedestal above the rest for its sensitivity in finding NETs, according to a study published Aug. 28 in the Journal of Nuclear Medicine.

Stem Cells reveal neurochemical flood in schizophrenics

Schizophrenia may be tripped off by an overabundance of chemical signals pumped out by neurons in the brain. The University of California, San Diego, announced Sept. 11 that researchers from the Skaggs School of Pharmacy and Pharmaceutical Sciences are using stem cells to see the flood of neurotransmitters first-hand.

Thumbnail

IBA and Philips to collaborate on cancer research and technology

Ion Beam Applications (IBA) announced today that the company will be teaming up with Philips Healthcare to develop new diagnostic and therapeutic research and technology, including proton therapy systems.

AAA acquires GE's FDG-PET sector in Italy

Advanced Accelerator Applications (AAA) announced today that it has acquired GE Healthcare’s FDG-PET radiopharmaceutical division in Italy.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.